Compare LMRI & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMRI | INVA |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2025 | 2004 |
| Metric | LMRI | INVA |
|---|---|---|
| Price | $14.44 | $19.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $22.67 | ★ $36.80 |
| AVG Volume (30 Days) | ★ 621.0K | 612.7K |
| Earning Date | 01-01-0001 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.96 |
| EPS | N/A | ★ 1.52 |
| Revenue | ★ $1,003,375,000.00 | $388,521,000.00 |
| Revenue This Year | $9.29 | $13.23 |
| Revenue Next Year | $5.01 | $8.58 |
| P/E Ratio | ★ N/A | $12.83 |
| Revenue Growth | 1.38 | ★ 10.14 |
| 52 Week Low | $14.00 | $16.52 |
| 52 Week High | $19.45 | $22.76 |
| Indicator | LMRI | INVA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 44.85 |
| Support Level | N/A | $19.29 |
| Resistance Level | N/A | $20.04 |
| Average True Range (ATR) | 0.00 | 0.50 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 45.94 |
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.